Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Triggering of lymphocyte antigen receptors is the critical first step in the adaptive immune response against pathogens. T cell receptor (TCR) ligation assembles a large membrane signalosome, culminating in NF-kappaB activation [1,2]. Recently,
caspase-8
was found to play a surprisingly prominent role in lymphocyte activation in addition to its well-known role in apoptosis [3]. Caspase-8 is activated after TCR stimulation and nucleates a complex with B cell lymphoma 10 (BCL10), paracaspase MALT1, and the inhibitors of kappaB kinase (IKK) complex [4]. We now report that the ubiquitin ligase TRAF6 binds to active
caspase-8
upon TCR stimulation and facilitates its movement into lipid rafts. We identified in silico two putative TRAF6 binding motifs in the
caspase-8
sequence and found that mutation of critical residues within these sites abolished TRAF6 binding and diminished TCR-induced NF-kappaB activation. Moreover, RNAi-mediated silencing of TRAF6 abrogated
caspase-8
recruitment to the lipid rafts. Protein kinase Ctheta (PKCtheta),
CARMA1
, and BCL10 are also required for TCR-induced
caspase-8
relocation, but only PKCtheta and BCL10 control
caspase-8
activation. Our results suggest that PKCtheta independently controls
CARMA1
phosphorylation and BCL10-dependent
caspase-8
activation and unveil an essential role for TRAF6 as a critical adaptor linking these two convergent signaling events.
...
PMID:Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. 1692 Jun 30
Humans and mice lacking functional
caspase-8
in T cells manifest a profound immunodeficiency syndrome due to defective T cell antigen receptor (TCR)-induced NF-kappaB signaling and proliferation. It is unknown how
caspase-8
is activated following T cell stimulation, and what is the
caspase-8
substrate(s) that is necessary to initiate T cell cycling. We observe that following TCR ligation, a small portion of total cellular
caspase-8
and c-FLIP(L) rapidly migrate to lipid rafts where they associate in an active caspase complex. Activation of
caspase-8
in lipid rafts is followed by rapid cleavage of c-FLIP(L) at a known
caspase-8
cleavage site. The active caspase.c-FLIP complex forms in the absence of Fas (CD95/APO1) and associates with the NF-kappaB signaling molecules RIP1, TRAF2, and TRAF6, as well as upstream NF-kappaB regulators PKC theta,
CARMA1
, Bcl-10, and MALT1, which connect to the TCR. The lack of
caspase-8
results in the absence of MALT1 and Bcl-10 in the active caspase complex. Consistent with this observation, inhibition of caspase activity attenuates NF-kappaB activation. The current findings define a link among TCR, caspases, and the NF-kappaB pathway that occurs in a sequestered lipid raft environment in T cells.
...
PMID:Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. 1746 96